Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.

Saved in:
Bibliographic Details
Title: Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.
Authors: Kamizela AE; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Leongamornlert D; Wellcome Sanger Institute, Hinxton, UK., Williams N; Wellcome Sanger Institute, Hinxton, UK., Wang X; Wellcome Sanger Institute, Hinxton, UK.; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Nyamondo K; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Dawson K; Wellcome Sanger Institute, Hinxton, UK., Spencer Chapman M; Wellcome Sanger Institute, Hinxton, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Guo J; Wellcome Sanger Institute, Hinxton, UK., Lee J; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Mane K; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Milne K; Cambridge University Hospitals NHS Trust, Cambridge, UK., Green AR; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Chevassut T; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Ellinor PT; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA., Huntly BJP; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Baxter EJ; Cambridge University Hospitals NHS Trust, Cambridge, UK., Nangalia J; Wellcome Sanger Institute, Hinxton, UK. jn5@sanger.ac.uk.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk.; Cambridge University Hospitals NHS Trust, Cambridge, UK. jn5@sanger.ac.uk.
Source: Nature [Nature] 2025 Apr; Vol. 640 (8060), pp. 982-990. Date of Electronic Publication: 2025 Apr 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40205062
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kamizela+AE%22">Kamizela AE</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Leongamornlert+D%22">Leongamornlert D</searchLink>; Wellcome Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Williams+N%22">Williams N</searchLink>; Wellcome Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nyamondo+K%22">Nyamondo K</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dawson+K%22">Dawson K</searchLink>; Wellcome Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Spencer+Chapman+M%22">Spencer Chapman M</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Guo+J%22">Guo J</searchLink>; Wellcome Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mane+K%22">Mane K</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Milne+K%22">Milne K</searchLink>; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Green+AR%22">Green AR</searchLink>; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Chevassut+T%22">Chevassut T</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Campbell+PJ%22">Campbell PJ</searchLink>; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ellinor+PT%22">Ellinor PT</searchLink>; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Huntly+BJP%22">Huntly BJP</searchLink>; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Baxter+EJ%22">Baxter EJ</searchLink>; Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Nangalia+J%22">Nangalia J</searchLink>; Wellcome Sanger Institute, Hinxton, UK. jn5@sanger.ac.uk.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk.; Cambridge University Hospitals NHS Trust, Cambridge, UK. jn5@sanger.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2025 Apr; Vol. 640 (8060), pp. 982-990. <i>Date of Electronic Publication: </i>2025 Apr 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40205062
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41586-025-08817-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 982
    Titles:
      – TitleFull: Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kamizela AE
      – PersonEntity:
          Name:
            NameFull: Leongamornlert D
      – PersonEntity:
          Name:
            NameFull: Williams N
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Nyamondo K
      – PersonEntity:
          Name:
            NameFull: Dawson K
      – PersonEntity:
          Name:
            NameFull: Spencer Chapman M
      – PersonEntity:
          Name:
            NameFull: Guo J
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Mane K
      – PersonEntity:
          Name:
            NameFull: Milne K
      – PersonEntity:
          Name:
            NameFull: Green AR
      – PersonEntity:
          Name:
            NameFull: Chevassut T
      – PersonEntity:
          Name:
            NameFull: Campbell PJ
      – PersonEntity:
          Name:
            NameFull: Ellinor PT
      – PersonEntity:
          Name:
            NameFull: Huntly BJP
      – PersonEntity:
          Name:
            NameFull: Baxter EJ
      – PersonEntity:
          Name:
            NameFull: Nangalia J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2025 Apr
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4687
          Numbering:
            – Type: volume
              Value: 640
            – Type: issue
              Value: 8060
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1